Loading...
•
Jan 31
Patterson Q3 2025 Earnings Report
Patterson Companies reported its third quarter operating results for fiscal year 2025, with a decrease in net sales and net income compared to the prior year.
Key Takeaways
Patterson Companies reported a decrease in net sales by 2.7% year-over-year to $1.57 billion for the third quarter of fiscal 2025. Diluted GAAP earnings per share were $0.35, down from $0.52 in the prior year, and adjusted earnings per share were $0.43, compared to $0.59 in the prior year. Both GAAP and adjusted earnings were negatively impacted by a cybersecurity attack on Change Healthcare.
Third quarter reported net sales decreased 2.7% year-over-year to $1.57 billion, with internal sales decreasing 2.4%.
GAAP diluted earnings per share were $0.35, and adjusted diluted earnings per share were $0.43, both negatively impacted by a cybersecurity attack on Change Healthcare.
The company returned $119.2 million to shareholders through cash dividends and share repurchases during the first nine months of fiscal 2025.
Patterson Dental segment's internal sales decreased 6.0%, with consumables down 6.2% and equipment down 6.9%.
Patterson
Patterson
Patterson Revenue by Segment
Revenue by Segment
Dental Revenue
CapyFin.comAnimal Health Revenue
CapyFin.com Forward Guidance
Patterson will not be providing an update to forward-looking earnings guidance due to the previously announced agreement to be acquired by Patient Square Capital. They will also not conduct a quarterly earnings call or publish supplemental earnings materials.
Revenue & Expenses
Visualization of income flow from segment revenue to net income